Fibromuscular dysplasia medical therapy: Difference between revisions
Line 9: | Line 9: | ||
==Medical Therapy== | ==Medical Therapy== | ||
[[ACE inhibitor]]s, and [[Angiotensin II receptor antagonist]]s are often initial treatments of fibromuscular dysplasia. Refractory cases are often treated by balloon angioplasty | [[ACE inhibitor]]s, and [[Angiotensin II receptor antagonist]]s are often initial treatments of fibromuscular dysplasia. Refractory cases are often treated by conventional balloon angioplasty of the renal artery. Stenting is often avoided. Besides [[hypertension|high blood pressure control]], [[platelet|anti-platelet]] drugs and [[blood thinner]] drugs may be used. | ||
==References== | ==References== |
Revision as of 00:32, 4 October 2012
Fibromuscular dysplasia Microchapters |
Diagnosis |
---|
Treatment |
ASA/ACCF/AHA Guideline Recommendations |
Management of Patients With Fibromuscular Dysplasia of the Extracranial Carotid Arteries |
Case Studies |
Fibromuscular dysplasia medical therapy On the Web |
American Roentgen Ray Society Images of Fibromuscular dysplasia medical therapy |
Risk calculators and risk factors for Fibromuscular dysplasia medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-in-Chief: Shantanu Sinha, MD,FACC
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Overview
Medical Therapy
ACE inhibitors, and Angiotensin II receptor antagonists are often initial treatments of fibromuscular dysplasia. Refractory cases are often treated by conventional balloon angioplasty of the renal artery. Stenting is often avoided. Besides high blood pressure control, anti-platelet drugs and blood thinner drugs may be used.